Kitatani, Kayoko <br/><br/>
Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.  [electronic resource] 

 -  Journal of bone and mineral metabolism  2003 
 - 217-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0914-8779 
<br/><br/><label>Standard No.: </label>10.1007/s00774-003-0412-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alkaline Phosphatase--analysis<br/>Amino Acids--metabolism<br/>Biomarkers--analysis<br/>Bone Density--drug effects<br/>Chromatography, High Pressure Liquid<br/>Enzyme-Linked Immunosorbent Assay<br/>Etidronic Acid--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteocalcin--analysis<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Predictive Value of Tests<br/>ROC Curve<br/>Sensitivity and Specificity<br/>Treatment Outcome